Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 Diabetes
Condition(s):Type 2 Diabetes; Blood Glucose FluctuationLast Updated:November 29, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Type 2 Diabetes; Blood Glucose FluctuationLast Updated:November 29, 2022Recruiting
Condition(s):Obesity; Insulin ResistanceLast Updated:August 31, 2012Withdrawn
Condition(s):Diabetes Mellitus, Type 2Last Updated:October 26, 2015Completed
Condition(s):PCOSLast Updated:September 13, 2021Completed
Condition(s):Diabetes Mellitus, Type 2Last Updated:August 30, 2023Active, not recruiting
Condition(s):Type 2 DiabetesLast Updated:March 20, 2019Withdrawn
Condition(s):PioglitazoneLast Updated:June 2, 2021Completed
Condition(s):Lipodystrophy; HIV InfectionLast Updated:June 20, 2016Completed
Condition(s):Type 2 Diabetes; Insulin Resistance; Metabolic SyndromeLast Updated:October 31, 2013Completed
Condition(s):Type II Diabetes MellitusLast Updated:September 12, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.